Report Detail
Global Enasidenib Drugs Market Insights, Forecast to 2025
- RnM3447650 |
- 22 May, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
The global Enasidenib Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Enasidenib Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Enasidenib Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Enasidenib Drugs in these regions.
This research report categorizes the global Enasidenib Drugs market by top players/brands, region, type and end user. This report also studies the global Enasidenib Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Celgene Corporation
Market size by Product
50mg
100mg
Market size by End User
Hospital
Pharmacy
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Enasidenib Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Enasidenib Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Enasidenib Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Enasidenib Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Enasidenib Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Enasidenib Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Enasidenib Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Enasidenib Drugs Market Size Growth Rate by Product
- 1.4.2 50mg
- 1.4.3 100mg
- 1.5 Market by End User
- 1.5.1 Global Enasidenib Drugs Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Pharmacy
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Enasidenib Drugs Market Size
- 2.1.1 Global Enasidenib Drugs Revenue 2014-2025
- 2.1.2 Global Enasidenib Drugs Sales 2014-2025
- 2.2 Enasidenib Drugs Growth Rate by Regions
- 2.2.1 Global Enasidenib Drugs Sales by Regions
- 2.2.2 Global Enasidenib Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Enasidenib Drugs Sales by Manufacturers
- 3.1.1 Enasidenib Drugs Sales by Manufacturers
- 3.1.2 Enasidenib Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Enasidenib Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Enasidenib Drugs Revenue by Manufacturers
- 3.2.1 Enasidenib Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Enasidenib Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Enasidenib Drugs Price by Manufacturers
- 3.4 Enasidenib Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Enasidenib Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Enasidenib Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Enasidenib Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Enasidenib Drugs Sales by Product
- 4.2 Global Enasidenib Drugs Revenue by Product
- 4.3 Enasidenib Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Enasidenib Drugs Breakdown Data by End User
6 North America
- 6.1 North America Enasidenib Drugs by Countries
- 6.1.1 North America Enasidenib Drugs Sales by Countries
- 6.1.2 North America Enasidenib Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Enasidenib Drugs by Product
- 6.3 North America Enasidenib Drugs by End User
7 Europe
- 7.1 Europe Enasidenib Drugs by Countries
- 7.1.1 Europe Enasidenib Drugs Sales by Countries
- 7.1.2 Europe Enasidenib Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Enasidenib Drugs by Product
- 7.3 Europe Enasidenib Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Enasidenib Drugs by Countries
- 8.1.1 Asia Pacific Enasidenib Drugs Sales by Countries
- 8.1.2 Asia Pacific Enasidenib Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Enasidenib Drugs by Product
- 8.3 Asia Pacific Enasidenib Drugs by End User
9 Central & South America
- 9.1 Central & South America Enasidenib Drugs by Countries
- 9.1.1 Central & South America Enasidenib Drugs Sales by Countries
- 9.1.2 Central & South America Enasidenib Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Enasidenib Drugs by Product
- 9.3 Central & South America Enasidenib Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Enasidenib Drugs by Countries
- 10.1.1 Middle East and Africa Enasidenib Drugs Sales by Countries
- 10.1.2 Middle East and Africa Enasidenib Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Enasidenib Drugs by Product
- 10.3 Middle East and Africa Enasidenib Drugs by End User
11 Company Profiles
- 11.1 Celgene Corporation
- 11.1.1 Celgene Corporation Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Celgene Corporation Enasidenib Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Celgene Corporation Enasidenib Drugs Products Offered
- 11.1.5 Celgene Corporation Recent Development
12 Future Forecast
- 12.1 Enasidenib Drugs Market Forecast by Regions
- 12.1.1 Global Enasidenib Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Enasidenib Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Enasidenib Drugs Market Forecast by Product
- 12.2.1 Global Enasidenib Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Enasidenib Drugs Revenue Forecast by Product 2019-2025
- 12.3 Enasidenib Drugs Market Forecast by End User
- 12.4 North America Enasidenib Drugs Forecast
- 12.5 Europe Enasidenib Drugs Forecast
- 12.6 Asia Pacific Enasidenib Drugs Forecast
- 12.7 Central & South America Enasidenib Drugs Forecast
- 12.8 Middle East and Africa Enasidenib Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Enasidenib Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Enasidenib Drugs . Industry analysis & Market Report on Enasidenib Drugs is a syndicated market report, published as Global Enasidenib Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Enasidenib Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
